Name
OÜ Chirurgicus
Registry code
10136321
VAT number
EE100666483
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
28.10.1996 (28)
Financial year
01.07-30.06
Capital
25 565.00 €
Activity
46461 - Wholesale of medicines and other pharmacy goods
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Ragnar Heido 14.09.1956 (68) | 100% - 25 565.00 EUR | Board member | Direct ownership |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Monemon Group OÜ 16017793 | 3% - 457.68 EUR | - | - |
| 2019 28.04.2021 | 2020 02.11.2022 | 2021 05.09.2023 | 2022 28.03.2024 | |
|---|---|---|---|---|
| Total Revenue | 1 584 470 € | 1 453 083 € | 1 111 779 € | 737 176 € |
| Net profit (loss) for the period | 174 671 € | 133 608 € | 175 427 € | 89 961 € |
| Profit Margin | 11% | 9% | 16% | 12% |
| Current Assets | 1 005 236 € | 1 408 702 € | 1 275 725 € | 827 765 € |
| Fixed Assets | 292 870 € | 278 433 € | 275 537 € | 281 935 € |
| Total Assets | 1 298 106 € | 1 687 135 € | 1 551 262 € | 1 109 700 € |
| Current Liabilities | 811 493 € | 1 191 081 € | 999 781 € | 532 958 € |
| Non Current Liabilities | 4 167 € | 0 € | - | - |
| Total Liabilities | 815 660 € | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 482 446 € | 496 054 € | 551 481 € | 576 742 € |
| Employees | 6 | 6 | 3 | 5 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 228 122.5 € | 19 547.52 € | 10 980.97 € | 6 |
| 2023 Q4 | 399 273 € | 26 894.4 € | 10 493.57 € | 6 |
| 2023 Q3 | 251 091 € | 25 911.7 € | 10 808.57 € | 6 |
| 2023 Q2 | 238 045.5 € | 24 034.92 € | 11 662.58 € | 6 |
| 2023 Q1 | 206 025.5 € | 27 427.03 € | 9 529.81 € | 6 |
| 2022 Q4 | 201 870.04 € | 21 360.01 € | 7 846.19 € | 6 |
| 2022 Q3 | 227 226.46 € | 30 092.05 € | 10 574.86 € | 6 |
| 2022 Q2 | 286 838.6 € | 27 008.25 € | 10 351.42 € | 6 |
| 2022 Q1 | 345 136.94 € | 29 641.06 € | 8 966.23 € | 6 |
| 2021 Q4 | 353 119.32 € | 30 747.41 € | 9 302.93 € | 6 |
| 2021 Q3 | 324 776.4 € | 21 222.26 € | 8 672.93 € | 6 |
| 2021 Q2 | 429 787.6 € | 29 630.58 € | 8 112.93 € | 6 |
| 2021 Q1 | 536 865.16 € | 33 399.4 € | 7 692.93 € | 7 |
| 2020 Q4 | 442 764 € | 40 473.94 € | 6 852.93 € | 7 |
| 2020 Q3 | 353 635.47 € | 27 036.1 € | 8 425.86 € | 7 |
| 2020 Q2 | 423 060.2 € | 24 057.33 € | 8 527.97 € | 7 |
| 2020 Q1 | 575 378.28 € | 24 835.82 € | 7 785.8 € | 7 |
